Gaithersburg, Md., April 18, 2016 – More than 700 leaders from life science companies, academic institutions, nonprofit organizations, investment funds and government entities across Maryland, Virginia and Washington, D.C. (MD-VA-DC) will convene today and tomorrow for the second annual Regional BioTech Forum. The event will showcase the region’s biotechnology accomplishments and its commitment to advancing cutting-edge research in the MD-VA-DC corridor. Notable speakers will include: Dr. Francis Collins, Director, National Institutes of Health; Maryland Governor Lawrence Hogan; Virginia Governor Terry McAuliffe; and Congressman John Delaney.
The Forum, hosted by AstraZeneca and its global biologics research and development arm, MedImmune, in partnership with BioHealth Innovation, Inc. (BHI), the Tech Council of Maryland, Inc. (TCM), GlycoMimetics, Inc. and Virginia Bio, will be held at MedImmune’s corporate headquarters in Gaithersburg. The program will build on a collective effort established last year to grow the region’s biotech ecosystem and help it to become one of the top three biotech hubs in the nation by 2023.
